QuidelOrtho Corp (QDEL) narrows full-year guidance as China revenue plunges 45%, while a new $80 million cost transformation program and breakeven free cash flow signal progress on deleveraging.
QuidelOrtho (NASDAQ:QDEL) reported third-quarter revenue of $619 million, down 12% year over year on a constant-currency basis, as China pricing changes and softer respiratory testing demand continued to weigh on results. The company said revenue rose 3% excluding China, respiratory testing and the
QuidelOrtho (QDEL) delivered earnings and revenue surprises of +72.22% and +0.60%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
--QuidelOrtho Corporation, a leading global provider of diagnostic solutions, has released episode 62 of its Science Bytes podcast, exploring best practices in AI and informatics to make lab operations smoother. Hosted by Josh Casey, this episode features QuidelOrtho's Vice President of Software Engineering for Global Informatics Platforms, Rodney Guzman,...
QuidelOrtho (QDEL) stock jumps 11% on heavy volume. Review key levels, RSI, short interest, and debt/covenant risks—read the latest analysis now.
QDEL's strong Q2 results, diversified product portfolio and cost-saving initiatives bolster its growth prospects despite persistent weakness in respiratory demand.
QuidelOrtho (NASDAQ:QDEL) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. Benzinga APIs provide real-time access to
Detailed price information for Quidelortho Corp (QDEL-Q) from The Globe and Mail including charting and trades.
Detailed price information for Merck & Company (MRK-N) from The Globe and Mail including charting and trades.
--QuidelOrtho Corporation, a global leader in in vitro diagnostics, is proud to share episode 61 of its Science Bytes podcast, highlighting key insights about lowering sepsis rates in the emergency room. Sepsis remains a leading cause of death in the U.S. Barriers to diagnosis lead to organ failure and higher mortality rates. Hosted by Josh Casey, this episode...
Detailed price information for Quidelortho Corp (QDEL-Q) from The Globe and Mail including charting and trades.
Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.
QuidelOrtho Corporation (Nasdaq: QDEL), a leading global provider of diagnostic solutions, has released episode 60 of its Science Bytes podcast, featuring highlights from the 2026 Association for Diagnostics and Laboratory Medicine (ADLM) Annual Conference.
This is the newest page. Registered accounts read further back.